Sign in to NCBI

Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA636399 ID: 636399

Temporal evolution of cellular heterogeneity during the progression to advanced, AR-negative prostate cancer [RRBS]

Navigate Up
This project is a component of the Temporal evolution of cellular heterogeneity during the progression to advanced, AR-negative prostate cancer
Navigate Across
4 additional projects are components of the Temporal evolution of cellular heterogeneity during the progression to advanced, AR-negative prostate cancer.
Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, acquired resistance ultimately ensues. More...
AccessionPRJNA636399; GEO: GSE151581
Data TypeEpigenomics
ScopeMultispecies
PublicationsBrady NJ et al., "Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.", Nat Commun, 2021 Jun 7;12(1):3372
Grants
  • "Weill Cornell Medicine (WCM) SPORE in Prostate Cancer" (Grant ID P50 CA211024, National Cancer Institute)
  • "Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer" (Grant ID R01 CA230913, National Cancer Institute)
SubmissionRegistration date: 1-Jun-2020
Pathology and Laboratory Medicine, Weill Cornell Medicine
RelevanceUnknown
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments8
Publications
PubMed1
PMC1
Other datasets
BioSample8
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Supplementary Mbytes241
SRA Data Details
ParameterValue
Data volume, Gbases83
Data volume, Mbytes25625

Supplemental Content

Related information

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI
Support Center